Guiding You to Treatment Success.
SPECIAL BONUS PODCAST with host Liz Graves. PROSTATE PROS interviews Dr. Marc Peck about his experience with prostate cancer. He describes the ups and downs of his journey starting with his diagnosis in 2001. Join Dr. Peck as he reflects on the past 20 years of living with prostate cancer. Liz: [00:04] Welcome to
Immunotherapy trains the patient’s own immune system to target and attack cancer cells. For men with prostate cancer immunotherapy can provide long-term efficacy with minimal side effects. This episode explores the innovations in immunotherapy including the use of off-label therapy and the promise of combination therapy. Don’t miss out on these new and exciting capabilities
For many people, chemotherapy conjures up thoughts of debilitating sickness and end of the line therapy. Today this is no longer the case. With advancements in modern medicine, side effects from chemotherapy can be easily managed and reduced. Chemotherapy treats metastatic disease and prevents relapse in men with prostate cancer. This episode of PROSTATE PROS
Hormone therapy, or Testosterone Inactivating Pharmaceuticals, work to either stop testosterone’s production or limit testosterone’s activity in promoting prostate cancer growth. These powerful anti-cancer drugs can put men with prostate cancer in remission for years and in some cases even decades! Discover hormone therapy treatment protocol and monitoring, get insight to hormone resistance, and learn
Historically radiation side effects and cure rates were not comparable to what surgery could achieve. However, with breakthroughs in radiation, computerized beam radiation now rivals surgery for cure rates and minimizes the risk of side effects.
This episode of PROSTATE PROS compares and contrasts the three types of computerized beam radiation: IMRT, IMPT, and SBRT. The episode also covers how to prevent and manage side effects of radiation therapy.
his episode explores and defines brachytherapy from the difference between HDR (temporary) and LDR (permanent) seeds, to who is eligible and why seeds might be an appealing treatment choice.